Harmony Biosciences Holdings Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Tessa Romero. I'm one of the senior biotechnology analysts here at JPMorgan. I'm joined by [Taylor Hamley] from the team. Our next presenting company is Harmony Biosciences, and presenting on behalf of the company, we have CEO, John Jacobs. (Operator Instructions)
With that, I will hand it over to John.
Thank you, Tessa, good morning, and good morning, everyone. I'd like to open the presentation by saying thank you very much for joining us and investing your time to learn more about our company, Harmony Biosciences, and happy new year to everyone. I'm also joined today by Sandip Kapadia, Harmony's CFO; Dr. Jeffrey Dayno, our Chief Medical Officer; and Jeffrey Dierks, our Chief Commercial Officer, who will be joining me for Q&A at the end of the formal presentation.
Next slide, please. Put up our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |